Healthcare | June 09, 2026
Agilus’s Idylla claims to deliver cancer mutation results in just 3 hours
Advanced molecular diagnostics solution enables rapid, high-accuracy biomarker detection for precision oncology
Advanced molecular diagnostics solution enables rapid, high-accuracy biomarker detection for precision oncology
Clara Sattler de Sousa e Brito to lead discovery solutions from Q3 2026, while Robert Machinek takes over as Head of Strategy & Business Development
Deal expands SPI Pharma’s manufacturing footprint in Germany, enhances pharmaceutical ingredient offerings, and reinforces focus on fast-growing digestive health market
The results come from post-hoc analyses of more than 1,500 women enrolled in the Phase 3 ATTAIN-1 and ATTAIN-2 trials, presented at the American Diabetes Association’s 86th Scientific Sessions
First installation of AI-powered AMULET SOPHINITY at NM Medical aims to strengthen early breast cancer detection
Dengue, a mosquito-borne viral disease, is emerging as a growing public health threat across Africa
The company will present 21 oral and poster presentations spanning investigational and approved therapies
The campaign places renewed focus on a disease that remains incurable despite major scientific advances
We are building the bridge between complex molecular data and everyday clinical decisions
Veteran pharma and biotech executive brings over 20 years of commercial leadership experience to support LMS's global CDMO and API growth strategy
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
